A Response to: Letter to the Editor Regarding ‘Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age’
Crossref DOI link: https://doi.org/10.1007/s40121-022-00719-4
Published Online: 2022-11-14
Published Print: 2023-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rozenbaum, Mark H.
Perdrizet, Johnna
Li, Xiuyan
Wasserman, Matt D.
Grant, Lindsay R.
Hayford, Kyla
Farkouh, Raymond A.
Text and Data Mining valid from 2022-11-14
Version of Record valid from 2022-11-14
Article History
Received: 19 October 2022
Accepted: 19 October 2022
First Online: 14 November 2022